SHERYL BINGHAM: Open Payments
NPI 1689181018 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 18 payments from 10 companies in 2025. Trend: 2023 $437 · 2024 $199 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $145 |
| Biogen, Inc. | 4 | $72 |
| Exeltis, USA Inc. | 3 | $53 |
| Solventum Corporation | 2 | $44 |
| Ethicon US, LLC | 1 | $40 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Wegovy, ZURZUVAE, SLYND, PREVENA, VISTASEAL, GEMTESA, LILETTA, OMNI HYSTEROSCOPE.
Industry payments across UT — which companies pay providers there.
